In several articles on this website, we have discussed the challenges of managing attention-deficit/ hyperactivity disorder (ADHD) during pregnancy and lactation/ breastfeeding. For links to these articles, please see Related Pages below.
In this article, we will answer the following question, which comes up repeatedly in my own clinical practice:
What are the potential risks of the amphetamine class of psychostimulant medications during lactation/breastfeeding (when they are taken under medical supervision and in therapeutic doses for the treatment of medical conditions like ADHD or narcolepsy)?